Related Experiment Video
Updated: Feb 4, 2026

Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
[Interleukin-10 receptor gene mutations induced very early onset inflammatory bowel disease in 6 infants]
1Department of Gastroenterology, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China.
Insights
Very early onset inflammatory bowel disease (VEO-IBD) in infants is linked to interleukin-10 receptor alpha subunit (IL-10RA) gene mutations. These mutations often cause severe symptoms and varied treatment responses.
Area of Science:
- Pediatric Gastroenterology
- Human Genetics
- Immunology
Background:
- Very early onset inflammatory bowel disease (VEO-IBD) presents a significant clinical challenge.
- Understanding the genetic underpinnings of VEO-IBD is crucial for diagnosis and management.
- Interleukin-10 receptor alpha subunit (IL-10RA) plays a role in immune regulation.
Purpose of the Study:
- To investigate the clinical manifestations of VEO-IBD in infants.
- To identify mutations in the IL-10RA gene in infants diagnosed with VEO-IBD.
- To correlate IL-10RA mutations with clinical phenotypes and treatment outcomes.
Main Methods:
- Retrospective review of clinical data from six infants with VEO-IBD.
- Analysis of symptoms, laboratory findings, colonoscopy, and pathology results.
- Genetic sequencing of the IL-10RA gene in all affected infants.
Main Results:
- All six infants presented with persistent diarrhea and fever within the first month of life.
- Common co-occurring symptoms included anemia, oral/perianal lesions, and growth retardation.
- IL-10RA gene mutations (homozygous and heterozygous) were identified in all patients, with c.301C>T and c.537G>A being frequent.
- Treatment responses were variable, with some improvement, worsening, and fatalities.
Conclusions:
- VEO-IBD is strongly associated with IL-10RA gene mutations.
- Patients often exhibit severe intestinal and extra-intestinal symptoms.
- Genetic analysis of IL-10RA is important for diagnosing VEO-IBD.
- Treatment outcomes for VEO-IBD associated with IL-10RA mutations can be unpredictable.
Abstract:
Objective: To analyze the clinical features and interleukin-10 receptor gene mutations in six infants with very early onset inflammatory bowel disease (VEO-IBD). Methods: Four girls and two boys with VEO-IBD admitted to Children's Hospital Affiliated to Capital Institute of Pediatrics from June 2016 to September 2017 were reviewed. The clinical data including general condition, clinical symptoms, laboratory tests, and colonoscopy and pathological results were collected and analyzed. Interleukin-10 receptor α subunit (IL-10RA) gene was examined in all patients. Results: Persistent diarrhea and fever were the most common symptoms and were found within 1 month after birth in all 6 patients. Anemia, oral ulcer or perianal lesions and growth retardation were common concomitant symptoms. All patients had colonoscopy examination and the results showed multiple ulcers affecting the colon with biopsies revealing acute and chronic inflammation. Three patients were found to have cryptitis and crypt abscesses. Gene sequencing revealed IL-10RA gene mutations in all six patients, including 3 cases with homozygous mutations (one with c.537G>A and two with c.301C>T) and 3 heterozygous mutations (paternal c.301C>T in all cases; maternal c.299T>G, c.350G>A and c.537G>A, respectively) . After conventional treatment, one got clinical and pathological improvement according to colonoscopy, three improved clinically, one worsened and died, and one died of septic shock secondary to intestinal perforation. Conclusions: VEO-IBD is associated with IL-10RA mutation, usually with severe intestinal symptoms and significant extra-intestinal symptoms, as well as varied responses to conventional treatment. In our study, c.301C>T and c.537G>A are the most common mutations.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Mutation, Gene Flow, and Genetic Drift

